Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.46ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.46ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.46EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.46EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CP.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CP.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CP.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CP.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CP.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.25ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.25ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.25EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.25EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BQ.1.1.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.23ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.23ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.23EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.23EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.18ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.18ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.18EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used